Related Experiment Video
Updated: Oct 14, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.8K
Lipid lowering in patients 75 years and older
Umidakhon Makhmudova1, P Christian Schulze1, Harry R Davis2
1Klinik für Innere Medizin I, Universitätsklinikum Jena, Jena 07747, Germany.
World Journal of Cardiology
|November 10, 2021
Summary
Ezetimibe, a cholesterol absorption inhibitor, shows significant benefits for elderly patients over 75. This review highlights its efficacy and suggests guideline updates for managing dyslipidemia in this population.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Cholesterol absorption is crucial for lipid management.
- Ezetimibe was the first cholesterol absorption inhibitor, approved over 20 years ago.
- Ezetimibe is a recognized therapy for lowering lipids.
Purpose of the Study:
- To review the evidence supporting ezetimibe's efficacy.
- To explore the pathophysiological mechanisms behind ezetimibe's benefits.
- To advocate for updated dyslipidemia guidelines regarding ezetimibe use in the elderly.
Main Methods:
- Literature review of relevant studies, including IMPROVE-IT and EWTOPIA 75.
- Analysis of pathophysiological mechanisms of cholesterol absorption inhibition.
- Synthesis of current evidence on ezetimibe in elderly populations.
Main Results:
- Ezetimibe has a long history of clinical application in lipid-lowering therapy.
- Recent studies suggest particular benefit in elderly patients aged over 75 years.
- Evidence supports ezetimibe's role in managing dyslipidemia.
Conclusions:
- Ezetimibe remains a valuable therapeutic option for lipid management.
- Elderly patients over 75 may experience substantial benefits from ezetimibe therapy.
- Current dyslipidemia guidelines may need revision to incorporate these findings.
Related Concept Videos
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
10
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
10
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
947
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
947
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
19
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
19
01:26Atherosclerosis III: Management
63
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
01:15Drug Dosing: Geriatric Patients
24
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
24
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
18
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
18